Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¶û°Ô¸£Çѽº¼¼Æ÷ Á¶Á÷±¸Áõ ȯ¾Æ¿¡¼­ ¹ß»ýÇÑ ¼Ó¹ß¼º °æÈ­¼º ´ã°ü¿° 1·Ê A Case of Secondary Sclerosing Cholangitis in Langerhans Cell Histiocytosis

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2001³â 4±Ç 1È£ p.120 ~ 124
±èÀÚÇü, ÃÖº¸È­, ±è°æ¸ð, ¹®Çü³²,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÀÚÇü ( Kim Ja-Hyeong ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç

ÃÖº¸È­ ( Choi Bo-Hwa ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç
±è°æ¸ð ( Kim Kyung-Mo ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç
¹®Çü³² ( Moon Hyung-Nam ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ¼­¿ïÁß¾Óº´¿ø ¼Ò¾Æ°úÇб³½Ç

Abstract

ÀúÀÚµéÀº º¹ºÎ Æظ¸°ú Áö¼ÓÀûÀΠȲ´ÞÀ» ÁÖ¼Ò·Î ³»¿øÇÑ ¶û°Ô¸£Çѽº¼¼Æ÷ Á¶Á÷±¸Áõ ȯ¾Æ¿¡¼­ °£Á¶Á÷°Ë»ç ¹× ³»½Ã°æÀû ¿ªÇ༺ ´ãµµÁ¶¿µ¼ú·Î Áø´ÜÇÑ ¼Ó¹ß¼º °æÈ­¼º ´ã°ü¿° 1·Ê¸¦ °æÇèÇÏ¿´±â¿¡ ¹®Çå °íÂû°ú ÇÔ²² º¸°íÇÏ´Â ¹ÙÀÌ´Ù.

Sclerosing cholangitis is a chronic cholestatic disease characterized by inflammation and obliterative fibrosis of the bile ducts, leading to biliary cirrhosis and ultimately to liver failure. In children, sclerosing cholangitis is known to be
associated with Langerhans cell histiocytosis, as well as with congenital immunodeficiencies and cystic fibrosis. Secondary sclerosing cholangitis is suspected in Langerhans cell histiocytosis with chronic cholestasis, liver dysfunction and portal hypertension. Unlike primary sclerosing cholangitis, the cholangitis associated Langerhans cell histiocytosis is destructive in nature and progresses more rapidly to biliary cirrhosis, therefore uniformly the prognosis is poor. In this setting, liver transplantation should be considered early in children with sclerosing cholangitis complicating Langerhans cell histiocytosis before end-stage liver failure and variceal bleeding. We experienced a case of secondary sclerosing cholangitis in Langerhans cell histiocytosis in a 2-year-old boy. We report this case with brief review of the related literatures.

Å°¿öµå

Secondary sclerosing cholangitis;Langerhans cell histiocytosis

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS